Regulation, rates, and real estate all made headlines in the financial-services sector in recent months and could create ongoing headwinds for several firms.
Five stats from the market and the stories behind them. This week: 17 months and no turnaround at J.C. Penney, a 14% drop-off for PCs, and more.
Five stats from the market and the stories behind them. This week: a shakeup in J.C. Penney's board, the DOJ seeks to ground a major airline merger, and BlackBerry mulls a sale.
High hopes for Greece, Fed action, Microsoft's new tablet, and J.C. Penney's turnaround topped the letdown list this week.
Unexpectedly robust sales of hepatitis C drug Olysio helped lift the drug giant’s pharma segment, while medical devices struggled, says Morningstar’s Damien Conover.
Vulnerability is growing at a handful of banks.
©2014 Morningstar Advisor. All right reserved.